FDA OKs New Adult Insomnia Med

The approval was based on a phase 3 trial showing daridorexant was associated with improved sleep onset, sleep maintenance, and daytime functioning in adults with insomnia.
FDA Approvals

source https://www.medscape.com/viewarticle/966295?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?